Clinical Trial Update: Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML [Phase 2]

View source ↗

Summary

Phase 2 study evaluating induction therapy with azacitidine and venetoclax followed by venetoclax maintenance in elderly patients with acute myeloid leukemia; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2026-04-07